Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Protection and Affordable Care Act | 20 | 2020 | 1188 | 4.160 |
Why?
|
| Politics | 21 | 2019 | 815 | 3.350 |
Why?
|
| Health Care Reform | 13 | 2020 | 1247 | 2.750 |
Why?
|
| State Health Plans | 6 | 2018 | 219 | 1.750 |
Why?
|
| Health Policy | 10 | 2021 | 2684 | 1.330 |
Why?
|
| Mandatory Programs | 4 | 2018 | 86 | 1.270 |
Why?
|
| Taxes | 4 | 2017 | 221 | 1.090 |
Why?
|
| Single-Payer System | 2 | 2017 | 35 | 1.050 |
Why?
|
| Medicaid | 8 | 2022 | 2818 | 1.040 |
Why?
|
| Delivery of Health Care | 9 | 2023 | 5336 | 0.990 |
Why?
|
| Oral Health | 3 | 2021 | 492 | 0.960 |
Why?
|
| Insurance Coverage | 6 | 2018 | 1940 | 0.910 |
Why?
|
| Insurance, Health | 6 | 2017 | 2498 | 0.760 |
Why?
|
| Organizational Innovation | 2 | 2022 | 537 | 0.730 |
Why?
|
| Health Plan Implementation | 2 | 2020 | 337 | 0.630 |
Why?
|
| Composite Resins | 1 | 2017 | 71 | 0.590 |
Why?
|
| Medicare | 6 | 2023 | 6770 | 0.570 |
Why?
|
| United States | 31 | 2023 | 72334 | 0.530 |
Why?
|
| Government | 1 | 2017 | 161 | 0.530 |
Why?
|
| State Government | 6 | 2018 | 384 | 0.520 |
Why?
|
| Bronchioles | 5 | 2020 | 30 | 0.500 |
Why?
|
| Cost Control | 1 | 2017 | 628 | 0.480 |
Why?
|
| Quality Improvement | 2 | 2022 | 3801 | 0.460 |
Why?
|
| Health Benefit Plans, Employee | 2 | 2015 | 333 | 0.450 |
Why?
|
| Budgets | 3 | 2013 | 230 | 0.450 |
Why?
|
| United States Government Agencies | 1 | 2013 | 26 | 0.440 |
Why?
|
| Advisory Committees | 1 | 2017 | 787 | 0.430 |
Why?
|
| X-Ray Microtomography | 5 | 2020 | 456 | 0.410 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 1668 | 0.390 |
Why?
|
| Supreme Court Decisions | 1 | 2012 | 133 | 0.360 |
Why?
|
| Financing, Government | 1 | 2013 | 472 | 0.330 |
Why?
|
| Federal Government | 3 | 2017 | 267 | 0.320 |
Why?
|
| Life Expectancy | 1 | 2016 | 1242 | 0.320 |
Why?
|
| Primary Prevention | 1 | 2016 | 1186 | 0.320 |
Why?
|
| Health Care Costs | 2 | 2017 | 3242 | 0.280 |
Why?
|
| Poverty | 1 | 2018 | 2698 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2020 | 3204 | 0.250 |
Why?
|
| Public Health | 2 | 2017 | 2669 | 0.230 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2022 | 63 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2017 | 1567 | 0.190 |
Why?
|
| Electrocardiography | 1 | 2014 | 6377 | 0.190 |
Why?
|
| Public Opinion | 2 | 2018 | 484 | 0.180 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 5440 | 0.180 |
Why?
|
| Government Regulation | 2 | 2017 | 524 | 0.180 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 3808 | 0.170 |
Why?
|
| Calcifediol | 1 | 2020 | 161 | 0.170 |
Why?
|
| History, 20th Century | 2 | 2017 | 2767 | 0.170 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 4420 | 0.170 |
Why?
|
| Calcitriol | 1 | 2020 | 296 | 0.160 |
Why?
|
| Bronchi | 2 | 2020 | 845 | 0.150 |
Why?
|
| Public Health Practice | 1 | 2020 | 219 | 0.150 |
Why?
|
| Lung Transplantation | 3 | 2020 | 1310 | 0.150 |
Why?
|
| Massachusetts | 4 | 2020 | 8830 | 0.140 |
Why?
|
| Humans | 33 | 2023 | 761504 | 0.140 |
Why?
|
| Community Health Centers | 1 | 2020 | 461 | 0.140 |
Why?
|
| Insurance, Dental | 1 | 2016 | 64 | 0.130 |
Why?
|
| Vital Statistics | 1 | 2016 | 31 | 0.130 |
Why?
|
| Abortion, Legal | 1 | 2017 | 114 | 0.130 |
Why?
|
| Vermont | 1 | 2015 | 81 | 0.130 |
Why?
|
| Lung | 4 | 2022 | 10000 | 0.130 |
Why?
|
| Cholecalciferol | 1 | 2020 | 553 | 0.120 |
Why?
|
| Airway Remodeling | 1 | 2016 | 133 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 385 | 0.110 |
Why?
|
| Torsades de Pointes | 1 | 2014 | 78 | 0.110 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 846 | 0.110 |
Why?
|
| Cost Sharing | 1 | 2016 | 409 | 0.100 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2014 | 213 | 0.100 |
Why?
|
| Vitamins | 1 | 2020 | 1635 | 0.100 |
Why?
|
| Dental Care | 1 | 2014 | 285 | 0.100 |
Why?
|
| Pulmonary Emphysema | 1 | 2017 | 684 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 652 | 0.090 |
Why?
|
| Airway Obstruction | 1 | 2016 | 661 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2016 | 824 | 0.090 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2016 | 515 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2014 | 467 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 1421 | 0.090 |
Why?
|
| Cystic Fibrosis | 2 | 2016 | 1285 | 0.080 |
Why?
|
| Child Health Services | 1 | 2014 | 646 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 450 | 0.080 |
Why?
|
| Case-Control Studies | 8 | 2022 | 22176 | 0.080 |
Why?
|
| Medical Indigency | 1 | 2006 | 63 | 0.070 |
Why?
|
| Social Justice | 1 | 2011 | 478 | 0.070 |
Why?
|
| Nutritional Status | 1 | 2011 | 1615 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Asthma | 1 | 2020 | 6234 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3358 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2020 | 58 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2014 | 4445 | 0.040 |
Why?
|
| Health Services Research | 1 | 2008 | 1812 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2020 | 114 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 315 | 0.040 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2020 | 131 | 0.040 |
Why?
|
| Health Promotion | 1 | 2011 | 2214 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 174 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2011 | 3188 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2020 | 155 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2020 | 271 | 0.040 |
Why?
|
| Violence | 1 | 2004 | 936 | 0.040 |
Why?
|
| Decision Making | 1 | 2011 | 3929 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 4016 | 0.030 |
Why?
|
| Residual Volume | 1 | 2016 | 41 | 0.030 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 2016 | 76 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2016 | 193 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 15842 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2004 | 1082 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2016 | 149 | 0.030 |
Why?
|
| Plethysmography | 1 | 2016 | 175 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2022 | 2601 | 0.030 |
Why?
|
| Middle Aged | 10 | 2022 | 220895 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2049 | 0.030 |
Why?
|
| Forecasting | 1 | 2003 | 2928 | 0.030 |
Why?
|
| Bronchography | 1 | 2014 | 75 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 971 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20570 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 390 | 0.030 |
Why?
|
| Spirometry | 1 | 2016 | 929 | 0.030 |
Why?
|
| Inpatients | 1 | 2004 | 2548 | 0.030 |
Why?
|
| Social Marketing | 1 | 2011 | 52 | 0.020 |
Why?
|
| Linear Models | 1 | 2022 | 5871 | 0.020 |
Why?
|
| Male | 10 | 2022 | 360804 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 2491 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 767 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1814 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2020 | 2598 | 0.020 |
Why?
|
| Female | 9 | 2022 | 392644 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2016 | 1119 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 731 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 943 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 1039 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 1479 | 0.020 |
Why?
|
| Aged | 5 | 2022 | 169289 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 1020 | 0.020 |
Why?
|
| Child | 1 | 2014 | 80153 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9420 | 0.020 |
Why?
|
| Disease Progression | 1 | 2022 | 13506 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20098 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10209 | 0.010 |
Why?
|
| Adult | 5 | 2022 | 221177 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4369 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6075 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4740 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15936 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8654 | 0.010 |
Why?
|
| Health Status | 1 | 2011 | 4077 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26125 | 0.010 |
Why?
|
| Smoking | 1 | 2012 | 9053 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 80636 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 59243 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 5079 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 58976 | 0.000 |
Why?
|
| Risk Factors | 1 | 2004 | 74206 | 0.000 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_